Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Persephone Biosciences
AddedMar 17, 2024
UpdatedJul 3, 2026
Persephone Biosciences

Persephone Biosciences

Seed

Persephone Biosciences crafts microbial drugs to fight cancer using AI and gut microbiome analysis.

HQ
San Diego, CA, US
Founded
2017
Accelerator
Y Combinator logoY CombinatorW18
Overview
Compare
Fundraising
Employees
Website

Persephone Biosciences, founded with the mission to end cancer through innovative biotherapeutic solutions, leverages the gut microbiome to develop treatments that modulate microbial metabolism. Utilizing advanced systems and synthetic biology, the company aims to understand and manipulate the complexities of the microbiome to prevent and cure diseases. Their primary focus is on creating live biotherapeutic products that can significantly impact disease progression, therapeutic response, nutrition, and longevity.

Notable figures affiliated with Persephone Biosciences include leading scientists and biotech investors who support its groundbreaking research. The company has achieved significant milestones in the development of AI-driven microbial drugs designed to combat cancer. Through its pioneering approach, Persephone Biosciences has made a substantial impact on the field of microbiome research and its application in disease treatment, positioning itself as a key player in the biotech industry.

Persephone Biosciences - Similar Companies

Petri Bio logo

Petri Bio

petribio.com

DeepBiome Therapeutics logo

DeepBiome Therapeutics

Serinus Biosciences logo

Serinus Biosciences

serinus.bio

MarvelBiome logo

MarvelBiome

marvelbiome.com

Parallel Bio logo

Parallel Bio

parallel.bio

Output Biosciences logo

Output Biosciences

outputbio.com

Biosortia Microbiomics logo

Biosortia Microbiomics

biosortia.com

Solarea Bio logo

Solarea Bio

solareabio.com

Vedanta Biosciences logo

Vedanta Biosciences

vedantabio.com

Seres Therapeutics logo

Seres Therapeutics

Vibe Bio logo

Vibe Bio

vibebio.com

Resilient Biotics logo

Resilient Biotics

Pragma Biosciences logo

Pragma Biosciences

pragmabio.com

Vulcan Biologics logo

Vulcan Biologics

Microbiome Therapeutics logo

Microbiome Therapeutics

Persephone Biosciences - Quick Facts

Who are Persephone Biosciences' competitors?

Companies similar to Persephone Biosciences include Petri Bio, DeepBiome Therapeutics, Serinus Biosciences and MarvelBiome.

When was Persephone Biosciences founded?

Persephone Biosciences was founded in 2017.

Where is Persephone Biosciences' headquarters located?

Persephone Biosciences' headquarters is located in San Diego, CA, US.

When was Persephone Biosciences' last funding round?

Persephone Biosciences' most recent funding round was for $15M (USD) in July 2022.

How much has Persephone Biosciences raised to-date?

As of Jul 19, 2022, Persephone Biosciences has raised a total of $15.2M (USD).

How many employees does Persephone Biosciences have?

Persephone Biosciences has 17 employees as of Feb 5, 2024.

Persephone Biosciences - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • AI
  • Biotech
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Biotherapeutics
  • Drugs
Tags
  • Biotech
  • Healthcare
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 15 more industry codes
NAICS
  • 513200Software Publishers
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 541700Scientific Research and Development Services
  • 513210Software Publishers
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research